Hepatitis Journal Options: Expert Commentaries

[Guest guest]

CME-CERTIFIED JOURNAL OPTIONS

Hepatitis Journal Options

Read our concise yet comprehensive Capsule Summaries of the latest and most

relevant hepatitis journal articles. This program also offers exclusive

commentaries on each journal article authored by leading experts in hepatology

and downloadable slidesets. Click here to review this collection.

Program Directors: T. Chung, MD; G. Gish, MD; and A.

on, MD, FACP

Expert Commentaries in this CME-certified collection include:

CLICK TO ACCESS

Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and

Peginterferon alfa-2a or alfa-2b

By Lawitz, MD

CLICK TO ACCESS

Improvement in Insulin Sensitivity With Protease Inhibitors in Genotype 1 HCV

By Hari S. Conjeevaram, MD, MSc

CLICK TO ACCESS

The Predictive Value of Serum HBsAg Quantitation in HBeAg-Positive Hepatitis B

By M. Di Bisceglie, MD, FACP

CLICK TO ACCESS

Differing HBsAg Outcomes During Peginterferon or Entecavir Monotherapy Support

Current Practices and Suggest Future Research Directions

By Tram T. Tran, MD

CLICK TO ACCESS

Long-term Treatment With Tenofovir for HBV/HIV Coinfection

By K. Sterling, MD, MSc, FACP, FACG

CLICK TO ACCESS

Tenofovir Rescue Therapy in Patients With Chronic Hepatitis B Who Have Failed

Both Lamivudine and Adefovir

By P. Perrillo, MD

CLICK TO ACCESS

Rifaximin Reverses Driving Difficulties in Patients With Minimal Hepatic

Encephalopathy

By Mullen, MD

CLICK TO ACCESS

Increasing Prevalence of NAFLD and NASH in the United States

By Brent A. Neuschwander-Tetri, MD

This CME-certified collection is located online at:

http://clinicaloptions.com/Hepatitis/Journal%20Options.aspx?id=059ca7f9-185c-442\

f-95a0-40406022e730

Jointly sponsored by the Annenberg Center for Health Sciences at Eisenhower and

Clinical Care Options, LLC.

Release date: March 23, 2011

Expiration date: March 22, 2012

Supported by educational grants from Bristol-Myers Squibb; Salix

Pharmaceuticals, Inc.; Three Rivers Pharmaceuticals; and Vertex.

Clinical Care Options Hepatitis

GET MORE FROM CCO

2011 Annual CCO HIV and Hepatitis C Symposium

Register today for the 2011 Annual CCO HIV and Hepatitis C Symposium for a

review of the most important scientific and clinical advances in the HIV and HCV

fields over the past year.

Click here for more information.

Conference Coverage

Journal Options

Management Series

Treatment Updates

Interactive Cases

Live Meetings

RSS / Podcasts

My CME Tracker

Free Bookstore

Slide Downloads

Copyright 2011 Clinical Care Options, LLC. All rights reserved. 1894 Preston

White Drive, Suite 110, Reston, VA 20191-5433

To ensure you receive Clinical Care Options educational materials by email,

please add info@... to your contacts or address book.

Not a member yet? Click here

[Guest guest]

CME-CERTIFIED JOURNAL OPTIONS

Hepatitis Journal Options

Read our concise yet comprehensive Capsule Summaries of the latest and most

relevant hepatitis journal articles. This program also offers exclusive

commentaries on each journal article authored by leading experts in hepatology

and downloadable slidesets. Click here to review this collection.

Program Directors: T. Chung, MD; G. Gish, MD; and A.

on, MD, FACP

Expert Commentaries in this CME-certified collection include:

CLICK TO ACCESS

Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and

Peginterferon alfa-2a or alfa-2b

By Lawitz, MD

CLICK TO ACCESS

Improvement in Insulin Sensitivity With Protease Inhibitors in Genotype 1 HCV

By Hari S. Conjeevaram, MD, MSc

CLICK TO ACCESS

The Predictive Value of Serum HBsAg Quantitation in HBeAg-Positive Hepatitis B

By M. Di Bisceglie, MD, FACP

CLICK TO ACCESS

Differing HBsAg Outcomes During Peginterferon or Entecavir Monotherapy Support

Current Practices and Suggest Future Research Directions

By Tram T. Tran, MD

CLICK TO ACCESS

Long-term Treatment With Tenofovir for HBV/HIV Coinfection

By K. Sterling, MD, MSc, FACP, FACG

CLICK TO ACCESS

Tenofovir Rescue Therapy in Patients With Chronic Hepatitis B Who Have Failed

Both Lamivudine and Adefovir

By P. Perrillo, MD

CLICK TO ACCESS

Rifaximin Reverses Driving Difficulties in Patients With Minimal Hepatic

Encephalopathy

By Mullen, MD

CLICK TO ACCESS

Increasing Prevalence of NAFLD and NASH in the United States

By Brent A. Neuschwander-Tetri, MD

This CME-certified collection is located online at:

http://clinicaloptions.com/Hepatitis/Journal%20Options.aspx?id=059ca7f9-185c-442\

f-95a0-40406022e730

Jointly sponsored by the Annenberg Center for Health Sciences at Eisenhower and

Clinical Care Options, LLC.

Release date: March 23, 2011

Expiration date: March 22, 2012

Supported by educational grants from Bristol-Myers Squibb; Salix

Pharmaceuticals, Inc.; Three Rivers Pharmaceuticals; and Vertex.

Clinical Care Options Hepatitis

GET MORE FROM CCO

2011 Annual CCO HIV and Hepatitis C Symposium

Register today for the 2011 Annual CCO HIV and Hepatitis C Symposium for a

review of the most important scientific and clinical advances in the HIV and HCV

fields over the past year.

Click here for more information.

Conference Coverage

Journal Options

Management Series

Treatment Updates

Interactive Cases

Live Meetings

RSS / Podcasts

My CME Tracker

Free Bookstore

Slide Downloads

Copyright 2011 Clinical Care Options, LLC. All rights reserved. 1894 Preston

White Drive, Suite 110, Reston, VA 20191-5433

To ensure you receive Clinical Care Options educational materials by email,

please add info@... to your contacts or address book.

Not a member yet? Click here